To check the efficacy of a new nanoform bone healing material in the clinical management of severe gum disease
Phase 4
Completed
- Conditions
- Health Condition 1: null- systemically healthy subjects with Chronic Periodontitis
- Registration Number
- CTRI/2017/03/008162
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
the presence of bilateral Class II furcation lesions (according to the classification given by Hamp et al, 1975), with vertical probing depth >5mm and horizontal probing depth >4mm
Exclusion Criteria
exclusion of through and through lesions. Patients with any known medical condition, or on a therapeutic regimen that would decrease the probability of soft tissue or bone healing, pregnant patients, smokers, patients who had undergone periodontal surgery in the last six months or were under any other clinical trial, patients allergic to tetracycline, chlorhexidine and who had any antibiotic medication in the last three months, and those not willing to consent for treatment and subsequent follow-up
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method bone fill and change in the class of the furcation defect, measured in terms of change in the horizontal probing depth.Timepoint: At 3 months and 6 months
- Secondary Outcome Measures
Name Time Method vertical probing depth, relative attachment level, gingival recessionTimepoint: baseline, 3months,6 months